PERROTTA, Silverio
 Distribuzione geografica
Continente #
NA - Nord America 5.608
EU - Europa 5.225
AS - Asia 775
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 9
OC - Oceania 4
Totale 11.647
Nazione #
US - Stati Uniti d'America 5.559
IE - Irlanda 1.661
IT - Italia 762
UA - Ucraina 721
GB - Regno Unito 664
DE - Germania 494
CN - Cina 371
SE - Svezia 252
SG - Singapore 222
FR - Francia 221
FI - Finlandia 196
GR - Grecia 134
TR - Turchia 75
BE - Belgio 46
CA - Canada 42
KR - Corea 23
PK - Pakistan 20
CH - Svizzera 13
IN - India 13
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
EU - Europa 10
ES - Italia 7
PL - Polonia 7
BR - Brasile 6
EG - Egitto 6
ET - Etiopia 6
NL - Olanda 6
VN - Vietnam 6
MX - Messico 5
DK - Danimarca 4
HK - Hong Kong 4
HU - Ungheria 4
ID - Indonesia 4
JP - Giappone 4
BG - Bulgaria 3
DZ - Algeria 3
IR - Iran 3
MK - Macedonia 3
MY - Malesia 3
RO - Romania 3
AT - Austria 2
AU - Australia 2
GE - Georgia 2
IL - Israele 2
IS - Islanda 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
IM - Isola di Man 1
IQ - Iraq 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RU - Federazione Russa 1
SC - Seychelles 1
TW - Taiwan 1
Totale 11.647
Città #
Dublin 1.651
Jacksonville 1.133
Chandler 902
Chicago 467
Princeton 249
Wilmington 237
Caserta 219
Medford 210
Boardman 187
Ann Arbor 184
Bremen 168
Falls Church 144
San Mateo 137
Singapore 130
Roxbury 127
Woodbridge 126
Beijing 122
New York 103
Ashburn 69
Nanjing 67
Cambridge 56
Des Moines 54
Napoli 46
Naples 41
Brussels 34
Redwood City 30
Elora 28
Grumo Nevano 28
Düsseldorf 27
Mountain View 27
Jinan 26
Seoul 23
Norwalk 22
Kunming 20
Helsinki 19
Milan 19
Nanchang 19
Houston 17
Munich 14
Rome 14
Auburn Hills 13
Pozzuoli 12
Shenyang 12
Brno 11
London 11
Nocera Inferiore 11
Riyadh 11
Kontich 10
Fairfield 9
Tianjin 9
Ningbo 8
Zhengzhou 8
Dearborn 7
Florence 7
Haikou 7
Lappeenranta 7
Oxford 7
Poggiomarino 7
Dong Ket 6
Guangzhou 6
Hangzhou 6
Hebei 6
Hefei 6
Lanzhou 6
Los Angeles 6
Parma 6
Scafati 6
Eboli 5
Islamabad 5
Portici 5
Salerno 5
Stella Cilento 5
Bologna 4
Centrale 4
Cutrofiano 4
Guadalajara 4
Lahore 4
Madrid 4
Marano Di Napoli 4
Ottawa 4
Padova 4
Pagani 4
Palma Campania 4
Seattle 4
Shanghai 4
Taizhou 4
Verona 4
Ariano Irpino 3
Aversa 3
Central 3
Changchun 3
Changsha 3
Città Sant'Angelo 3
Council Bluffs 3
Frankfurt am Main 3
Frederiksberg 3
Garlate 3
Gunzenhausen 3
Hyderabad 3
Leawood 3
Totale 7.541
Nome #
Osteoporosis in thalassemia major: A possible role of chelation therapy. 754
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells. 113
The Italian survey on hereditary spherocytosis 108
Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions 93
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 85
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 84
Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology. 82
Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification 79
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 78
Erythrocyte genotyping for transfusion-dependent patients at the Azienda Universitaria Policlinico of Naples 75
Very early onset of autoimmune thyroiditis in a toddler with severe hypothyroidism presentation: A case report 74
Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: Evidence for a differentiated splenic conditioning role 73
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation) 73
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 72
A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia 72
LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies. 71
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 71
Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders 70
Early-onset central diabetes insipidus is associated with de novo arginine vasopressin-neurophysin II or Wolfram syndrome 1 gene mutations 69
p27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases. 68
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 67
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 67
ERITROCITOSI CONGENITA CAUSATA DA ALTERAZIONI DEL SISTEMA SENSORE DELL’OSSIGENO 66
Childhood Head and Neck Lymphadenopathy: A Report by a Single Institution (2003-2017) 66
Targeted molecular therapy (modified RIST regimen) in relapsed high risk stage IV neuroblastoma: two cases report 65
The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function 64
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy 63
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. 63
Vitamin A and infancy. Biochemical, functional, and clinical aspects 63
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin 62
Vitamin A and infancy. Biochemical, functional, and clinical aspects 62
A cancer-associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss-of-function 62
Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ANK1) allele 61
Alpha I/65 hereditary elliptocytosis in southern Italy: evidence for an African origin 61
Arg(1809) substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1 61
National systematic approach to the management of asplenia: the set up of the Italian Network on Asplenia 61
Frequent de novo monoallelic expression of beta-spectrin gene (SPTB) in children with hereditary spherocytosis and isolated spectrin deficiency 60
Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition 60
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 60
Ankyrin Napoli: a de novo deletional frameshift mutation in exon 16 of ankyrin gene (ANK1) associated with spherocytosis 60
Resveratrol mimics insulin activity in the adipogenic commitment of human bone marrow mesenchymal stromal cells. 60
Tumori renali: esperienza trentennale monoistituzionale 60
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 60
Erythropoietin receptors on cancer cells: a still open question. 59
A deletional frameshift mutation in spectrin beta-gene associated with hereditary elliptocytosis in spectrin Napoli 59
Concordanza tra visita oculistica e RM encefalo nello screening del glioma delle vie ottiche nei pazienti pediatrici con neurofibromatosi tipo 1 59
Studio retrospettivo sulle complicanze emato-oncologiche nella neurofibromatosi tipo 1 in età pediatrica 59
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 58
Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis 58
Abnormalities of erythrocyte glycoconjugates are identical in two families with congenital dyserythropoietic anemia type II with different chromosomal localizations of the disease gene 58
Unusual association of non-anaplastic Wilms tumor and Cornelia de Lange syndrome: Case report 58
Seizures in children with neurofibromatosis type 1: Is neurofibromatosis type 1 enough? 58
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. 57
Hereditary spherocytosis (HS) due to loss of anion exchange transporter 57
Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene. 57
Increased Membrane‐Protein Methylation in Hereditary Spherocytosis: A Marker of Cytoskeletal Disarray 56
{beta}-spectrinBari: a truncated {beta}-chain responsible for dominant hereditary spherocytosis. 56
Multiple spinal nerve enlargement and SOS1 mutation: further evidence of overlap between Neurofibromatosis type 1 and Noonan phenotype 56
Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1 56
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 56
A genome search for primary vesicoureteral reflux shows further evidence for genetic heterogeneity 55
Analysis of N-ras gene mutations in medulloblastomas by polymerase chain reaction and oligonucleotide probes in formalin-fixed, paraffin-embedded tissues 55
Frequent de novo mutations of the ANK1 gene mimic a recessive mode of transmission in hereditary spherocytosis: three new ANK1 variants: ankyrins Bari, Napoli II and Anzio 55
Glucose 6-phosphate dehydrogenase deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia 55
Genetic basis of congenital erythrocytosis: mutation update and online databases. 55
Cardiac autonomic regulation in response to a mixed meal is impaired in obese children and adolescents: the role played by insulin resistance. 55
Identificazione di una mutazione del gene PAX2 in una famiglia con RVU isolato 54
Time trends of cancer incidence in childhood in Campania region: 25 years of observation 54
Abbreviated breast magnetic resonance imaging (FAST-MRI): A novel approach to breast cancer screening in patients with previous Hodgkin lymphoma 54
Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus. 53
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 53
A rapid method for the detection of alpha I/65 hereditary elliptocytosis 53
Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience 53
Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior 52
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study. 52
Mild elliptocytosis associated with the alpha 34 Arg-->Trp mutation in spectrin Genova (alpha I/74) 52
L1 effects on reactive oxygen (ROS) and nitrogen species (RNS) release, hemoglobin oxidation, low molecular weight antioxidants, and antioxidant enzyme activities in red and white blood cells of thalassemic patients 51
Evaluation of leptin protein levels in patients with Cooley's anaemia 51
4.2 Nippon mutation in a non-Japanese patient with hereditary spherocytosis [3] 51
Deferasirox: la chelazione ottimale nelle anemie trasfusione-dipendenti 51
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 51
Blood transfusions and adverse acute events: a retrospective study from 214 transfusion-dependent pediatric patients comparing transfused blood components by apheresis or by whole blood 51
Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. 50
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3. 50
COINHERITANCE OF GILBERT SYNDROME INCREASES THE RISK FOR DEVELOPING GALLSTONES IN PATIENTS WITH HEREDITARY SPHEROCYTOSIS 50
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study 50
Splenectomy for hereditary spherocytosis: complete, partial or not at all? 50
ROBO2 gene variants are associated with familial vesicoureteral reflux 49
Characterization of red cell membrane proteins as a function of red cell density: Annexin VII in different forms of hereditary spherocytosis 49
Genomewide search for dehydrated hereditary stomatocytosis (hereditary xerocytosis): mapping of locus to chromosome 16 (16q23-qter) 49
Frequency of congenital dyserythropoietic anemias in Europe 49
Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects 49
Ankyrin deficiency in dominant hereditary spherocytosis: report of three cases 49
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 49
Hereditary spherocytosis characterized by increased spectrin/band 3 ratio 48
Non-allelic heterogeneity in familial unilateral renal adysplasia 48
Organizing national responses for rare blood disorders: The Italian experience with sickle cell disease in childhood 48
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 48
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 48
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 48
Totale 6.722
Categoria #
all - tutte 50.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.029 0 0 84 26 207 44 271 70 168 39 84 36
2020/20211.772 175 19 185 131 284 31 257 189 26 231 183 61
2021/20221.995 175 58 63 86 543 34 105 69 78 140 179 465
2022/20233.880 389 152 336 302 378 295 12 192 1.612 35 100 77
2023/20241.272 105 40 69 137 426 120 22 56 24 11 87 175
2024/202570 28 41 1 0 0 0 0 0 0 0 0 0
Totale 12.178